These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 29634566)
21. EVALUATION OF EFFICIENCY OF IMIGLUCERASE (CEREZYME) IN THE TREATMENT OF GAUCHER DISEASE (CASE REPORTS AND REVIEW OF THE LITERATURE). Samohalska O; Kornaga S; Mandziy Z; Boiko T; Radetska L Georgian Med News; 2018 Feb; (Issue):69-73. PubMed ID: 29578427 [TBL] [Abstract][Full Text] [Related]
22. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease]. Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655 [TBL] [Abstract][Full Text] [Related]
23. Failed epidural analgesia in a parturient with advanced ankylosing spondylitis: a novel explanation. Hoffman SL; Zaphiratos V; Girard MA; Boucher M; Crochetière C Can J Anaesth; 2012 Sep; 59(9):871-4. PubMed ID: 22806062 [TBL] [Abstract][Full Text] [Related]
24. Use of epidural clonidine for the management of analgesia in the opioid addicted parturient on buprenorphine maintenance therapy: an observational study. Hoyt MR; Shah U; Cooley J; Temple M Int J Obstet Anesth; 2018 May; 34():67-72. PubMed ID: 29486974 [TBL] [Abstract][Full Text] [Related]
26. Alglucerase enzyme replacement therapy used safely and effectively throughout the whole pregnancy of a Gaucher disease patient. Aporta Rodriguez R; Escobar Vedia JL; Navarro Castro AM; Aguilar García G; Cabrera Torres A Haematologica; 1998 Sep; 83(9):852-3. PubMed ID: 9825582 [TBL] [Abstract][Full Text] [Related]
27. Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. Ben Turkia H; Gonzalez DE; Barton NW; Zimran A; Kabra M; Lukina EA; Giraldo P; Kisinovsky I; Bavdekar A; Ben Dridi MF; Gupta N; Kishnani PS; Sureshkumar EK; Wang N; Crombez E; Bhirangi K; Mehta A Am J Hematol; 2013 Mar; 88(3):179-84. PubMed ID: 23400823 [TBL] [Abstract][Full Text] [Related]
28. Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease. Elstein D; Hughes D; Goker-Alpan O; Stivel M; Baris HN; Cohen IJ; Granovsky-Grisaru S; Samueloff A; Mehta A; Zimran A J Obstet Gynaecol Res; 2014 Apr; 40(4):968-75. PubMed ID: 24612151 [TBL] [Abstract][Full Text] [Related]
29. Neuraxial labor analgesia in a parturient with carnitine palmitoyl transferase type II deficiency: a case report. Bowman TK; Oweidat A; El Hage Chehade N; Cheriyan M; Ayad S; Hoyt M Int J Obstet Anesth; 2024 Nov; 60():104246. PubMed ID: 39209572 [TBL] [Abstract][Full Text] [Related]
30. Characteristics of type I Gaucher disease associated with persistent thrombocytopenia after treatment with imiglucerase for 4-5 years. Hollak CE; Belmatoug N; Cole JA; Vom Dahl S; Deegan PB; Goldblatt J; Rosenbloom B; van Dussen L; Tylki-Szymańska A; Weinreb NJ; Zimran A; Cappellini MD Br J Haematol; 2012 Aug; 158(4):528-38. PubMed ID: 22640238 [TBL] [Abstract][Full Text] [Related]
31. Reported outcomes of 453 pregnancies in patients with Gaucher disease: An analysis from the Gaucher outcome survey. Lau H; Belmatoug N; Deegan P; Goker-Alpan O; Schwartz IVD; Shankar SP; Panahloo Z; Zimran A Blood Cells Mol Dis; 2018 Feb; 68():226-231. PubMed ID: 27839985 [TBL] [Abstract][Full Text] [Related]
32. [Epidural analgesia in a woman with spinal neurostimulation for complex regional pain syndrome type 1. A clinical case and a literature review]. Domínguez Suárez E; Camblor Suárez E; Vázquez Del Valle S; López Rouco M; Rodríguez Vázquez ML Rev Esp Anestesiol Reanim; 2012 Nov; 59(9):515-6. PubMed ID: 22809579 [No Abstract] [Full Text] [Related]
33. Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase. Smith L; Rhead W; Charrow J; Shankar SP; Bavdekar A; Longo N; Mardach R; Harmatz P; Hangartner T; Lee HM; Crombez E; Pastores GM Mol Genet Metab; 2016 Feb; 117(2):164-71. PubMed ID: 26043810 [TBL] [Abstract][Full Text] [Related]
34. Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease. Séllos-Moura M; Barzegar S; Pan L; Shi P; Oommen S; Durant J; Ruiz JA J Immunol Methods; 2011 Oct; 373(1-2):45-53. PubMed ID: 21846471 [TBL] [Abstract][Full Text] [Related]
35. Uneventful epidural analgesia in a patient with severe thrombocytopenia. Ibrahim SM; ElGazali MS Middle East J Anaesthesiol; 2009 Jun; 20(2):291-4. PubMed ID: 19583082 [TBL] [Abstract][Full Text] [Related]
36. Effects of switching from imiglucerase to velaglucerase alfa without dose reduction nor wash out in type 1 Gaucher disease. Serratrice C; Bengherbia M; Alessandrini M; Grosbois B; Camou F; Pers YM; Bismuth M; Marie I; Belmatoug N; Berger M; Blood Cells Mol Dis; 2014; 53(1-2):94-6. PubMed ID: 24411065 [No Abstract] [Full Text] [Related]
37. Intrathecal Migration of an Epidural Catheter While Using a Programmed Intermittent Epidural Bolus Technique for Labor Analgesia Maintenance: A Case Report. Betti F; Carvalho B; Riley ET A A Case Rep; 2017 Dec; 9(12):357-359. PubMed ID: 28767472 [TBL] [Abstract][Full Text] [Related]
38. Anesthetic management of a parturient with Behcet's disease and suspected arrhythmogenic right ventricular dysplasia. Giuri PP; Gonnella GL; Catarci S; Ciancia M; Draisci G Korean J Anesthesiol; 2020 Feb; 73(1):75-76. PubMed ID: 31216845 [No Abstract] [Full Text] [Related]
39. Breastfeeding in Gaucher disease: is enzyme replacement therapy safe? Dornelles AD; de Oliveira Netto CB; Vairo F; de Mari JF; Tirelli KM; Schwartz IV Clin Ther; 2014 Jun; 36(6):990-1. PubMed ID: 24768190 [No Abstract] [Full Text] [Related]